Flosequinan
Risk Factor: CM
Class: CARDIOVASCULAR DRUGS
/ Vasodilators
Contents of this page:
Fetal Risk Summary
Breast Feeding Summary
References
Questions and Answers
Fetal Risk Summary
Flosequinan is a systemic vasodilator used in the treatment of congestive heart failure. In rats and rabbits, the drug crosses the placenta to the fetus and has been measured in amniotic fluid (1). Fetotoxicity, including delayed calcification, intrauterine deaths, and low fetal viability have been observed in the two animal species. No reports describing the use of this agent in human pregnancy have been located.
Breast Feeding Summary
No data are available.
References
-
Product information. Manoplax. Boots Pharmaceuticals, Inc., 1993.
